Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04712604 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability Study of My Sleep Our Sleep (MSOS) Program
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04712604: Completed NA study, sponsored by University of Miami.
NCT04712604 is a NA study that has completed, run by University of Miami. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04712604, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to test feasibility and acceptability of a psycho-behavioral intervention on sleep in cancer patients and their partners.
Primary Outcome
Feasibility of the intervention will be reported as the percentage of participants who enroll and complete all the sessions of the study.
Interventions
- BEHAVIORAL My Sleep Our Sleep (MSOS) Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2021-03-14 |
| Est. Completion | 2022-01-25 |
| Phase | NA |
What the finished NCT04712604 record still lists
NCT04712604 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which My Sleep Our Sleep (MSOS) Program is the first listed.
NCT04712604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04712604 about?
NCT04712604 is a clinical study titled "Feasibility and Acceptability Study of My Sleep Our Sleep (MSOS) Program". The purpose of this study is to test feasibility and acceptability of a psycho-behavioral intervention on sleep in cancer patients and their partners.
What is the current status of trial NCT04712604?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2021-03-14. Estimated completion is 2022-01-25.
What interventions are being tested in trial NCT04712604?
The interventions under investigation include: My Sleep Our Sleep (MSOS) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04712604?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04712604's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI